Insider · CIK 0001808290

Ordonez Claudia

Reports to the SEC for 1 company · LEXINGTON, MA

sec.gov

Transactions

Companies

Filings

CIK

0001808290

Forms 4 and 5

Insider transactions

25 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2021-06-11	KROSKeros Therapeutics, Inc.M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+1,000 sh	$0.48	+$480	1,000
2021-06-11	KROSKeros Therapeutics, Inc.S Sale	Chief Medical Officer	SSale	−653 sh	$50.48	−$33K	347
2021-06-11	KROSKeros Therapeutics, Inc.S Sale	Chief Medical Officer	SSale	−347 sh	$51.95	−$18K	0
2021-06-11	KROSKeros Therapeutics, Inc. · Employee Stock Option (right to buy)M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	−1,000 sh	—	—	98,211
2021-05-11	KROSKeros Therapeutics, Inc.M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+1,000 sh	$0.48	+$480	1,000
2021-05-11	KROSKeros Therapeutics, Inc.S Sale	Chief Medical Officer	SSale	−1,000 sh	$50.15	−$50.2K	0
2021-05-11	KROSKeros Therapeutics, Inc. · Employee Stock Option (right to buy)M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	−1,000 sh	—	—	99,211
2021-04-12	KROSKeros Therapeutics, Inc.M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+1,000 sh	$0.48	+$480	1,000
2021-04-12	KROSKeros Therapeutics, Inc.S Sale	Chief Medical Officer	SSale	−400 sh	$59.09	−$23.6K	600
2021-04-12	KROSKeros Therapeutics, Inc.S Sale	Chief Medical Officer	SSale	−367 sh	$60.01	−$22K	233
2021-04-12	KROSKeros Therapeutics, Inc.S Sale	Chief Medical Officer	SSale	−233 sh	$61.23	−$14.3K	0
2021-04-12	KROSKeros Therapeutics, Inc. · Employee Stock Option (right to buy)M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	−1,000 sh	—	—	100,211
2021-03-11	KROSKeros Therapeutics, Inc.M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+1,000 sh	$0.48	+$480	1,000
2021-03-11	KROSKeros Therapeutics, Inc.S Sale	Chief Medical Officer	SSale	−395 sh	$64.09	−$25.3K	605
2021-03-11	KROSKeros Therapeutics, Inc.S Sale	Chief Medical Officer	SSale	−605 sh	$64.86	−$39.2K	0
2021-03-11	KROSKeros Therapeutics, Inc. · Employee Stock Option (right to buy)M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	−1,000 sh	—	—	101,211
2021-02-11	KROSKeros Therapeutics, Inc.M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+1,000 sh	$0.48	+$480	1,000
2021-02-11	KROSKeros Therapeutics, Inc.S Sale	Chief Medical Officer	SSale	−175 sh	$63.10	−$11K	825
2021-02-11	KROSKeros Therapeutics, Inc.S Sale	Chief Medical Officer	SSale	−312 sh	$64.17	−$20K	513
2021-02-11	KROSKeros Therapeutics, Inc.S Sale	Chief Medical Officer	SSale	−216 sh	$65.35	−$14.1K	297
2021-02-11	KROSKeros Therapeutics, Inc.S Sale	Chief Medical Officer	SSale	−295 sh	$66.19	−$19.5K	2
2021-02-11	KROSKeros Therapeutics, Inc.S Sale	Chief Medical Officer	SSale	−2 sh	$68.05	−$136.1	0
2021-02-11	KROSKeros Therapeutics, Inc. · Employee Stock Option (right to buy)M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	−1,000 sh	—	—	102,211
2021-01-10	KROSKeros Therapeutics, Inc. · Employee Stock Option (right to buy)A Award	Chief Medical Officer	AAward	+42.3K sh	—	—	42,250
2020-04-07	KROSKeros Therapeutics, Inc. · Employee Stock Option (right to buy)A Award	Chief Medical Officer	AAward	+18.4K sh	—	—	18,430

Recent filings

Accepted (ET)
Jun 154
Ordonez Claudia0001209191-21-040648
SEC(opens sec.gov)
May 134
Ordonez Claudia0001209191-21-032361
SEC(opens sec.gov)
Apr 144
Ordonez Claudia0001209191-21-026669
SEC(opens sec.gov)
Mar 154
Ordonez Claudia0001209191-21-020483
SEC(opens sec.gov)
Feb 164
Ordonez Claudia0001209191-21-010882
SEC(opens sec.gov)

Companies

Keros Therapeutics, Inc.Chief Medical OfficerKROS

Address

C/O KEROS THERAPEUTICS, INC. 99 HAYDEN AVENUE, SUITE 120, BUILDING E

LEXINGTON, MA, 02421